COVID-19 Vaccine Rollout: Johnson & Johnson (J&J) - Macroeconomic Business Report

This technical macroeconomic report explores the strategic changes and challenges faced by Johnson & Johnson (J&J) in light of COVID-19. The multifaceted analysis, employing a PESTEL framework, supply and demand analysis and game theory highlighting how the pandemic has dramatically shifted the operational and strategic environment for J&J. The company grapples with intense social, legal, and political pressures to rapidly develop vaccines while ensuring their safety and accessibility. Financial challenges are underscored by high R&D costs and tight profit margins, exacerbated by the need for quick adaptation to changing government regulations and public health needs. The recommendation is for J&J to continue focusing on vaccine accessibility and safety, leveraging government partnerships to sustain innovation and meet global health demands effectively.

Prepared by: Marlon Holloway (June 2022)